Our in vivo studies suggest that macrophage CD36 similarly contributes to the pathogenesis of IBD by facilitating the transport and accumulation of diet-derived lipids in macrophages, altering macrophage responses to microbial signals. Here, CD36 is linked to inflammatory bowel disease.